Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in Asia

The purpose of this study is to describe the short-and long-tern (i.e. up to 2 years following the index event) AMPs in patients hospitalized for an acute coronary syndrome (i.e. STEMI or NSTE-ACS), and to document clinical outcomes, economic aspects and impact on quality of life of these AMPs in a 'real-life' setting.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Coronary Syndrome Cardiovascular Diseases Heart Diseases Myocardial Ischemia Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Hefei, Anhui, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Written informed consent has been provided.
Diagnosis of STEMI, NSTEMI or UA
Hospitalization for the first time within 48 hours of onset of symptoms.

Exclusion criteria

UA, STEMI, NSTEMI precipitated by or as a complication of surgery, trauma, or GI bleeding or post-PCI UA, STEMI and NSTEMI occurring in patients already hospitalized for other reasons.
Current participation in a randomised interventional clinical trial.

Treatment and study plan

Primary outcomes

short- and long-term medication and treatment prescribed by physicians in real-life setting

Time frame: up to 3 years

Secondary outcomes

clinical outcome (Cardiovascular events)

Time frame: up to 3 years
cost of hospitalization

Time frame: up to 3 years
quality of life (EQ-5D questionnaire)

Time frame: up to 3 years

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Acronym: EPICOR ASIA

Important dates

Study start: 2011
Primary completion: 2014
Study completion: 2014
First posted: May 26, 2011
Registry last updated: Jun 16, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed